Resources

Relation Therapeutics announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis

Stablepharma Named Life Sciences Innovation Awards Winner by Leading US News Platform, Fierce Pharma, in the “Biotech Innovation” Category

OMass Therapeutics Strengthens its Leadership Team with the Promotions of Hsin Loke to Chief Operating officer and Jon Roffey to Senior Vice President, Discovery and Non-Clinical

With a new Labour Government in place, this year’s event set the stage for impactful collaboration with MPs and policymakers. Read on to learn how we’re keeping life sciences at the top of the agenda.

Coulter Partners successfully completed a search assignment for Curve Therapeutics (“Curve”) and is pleased to announce the placement of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer.

The Innovation Ecosystem Programme, an 18-month-long NHS England project, which the BIA have been involved in throughout, describes how the UK can lead the way globally in health gains and life sciences powered growth. Its final report was published last week.

Brainomix, a pioneer in artificial intelligence (AI) imaging solutions, has been awarded the LSX European Lifestars Award for “Healthtech Company of the Year” by HSBC Innovation Banking, and the “Most Transformative Healthtech Company of the Year” by OBN.

A new total-body PET scanner that is quicker for the patient and produces higher quality images for faster and earlier diagnosis and treatment of illnesses like cancer and heart conditions, was unveiled by Ministers in London yesterday (Wednesday 27 November).

A new independent report evaluating the economic and scientific impact of the Babraham Research Campus has revealed significant contributions not only to the UK and global life sciences sector, but to the local Cambridge and wider UK economy.

Vitarka Therapeutics Ltd, the EndoPore® cancer therapeutics company, today announced the appointment of Dr John Beadle as the new Chairman of the Board.

The North West of England is recognised as one of the cornerstones of the UK’s life sciences  sector. This enduring strength positions the North West as a hub of national significance for life sciences manufacturing.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Entia and is pleased to announce the placement of Timothy Broke-Smith as Senior Vice President of Partnerships.

London was the epicentre of the life science industry during London Life Sciences Week last week. The 2024 edition marked a significant step forward in both the quality and quantity of events and interactions.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the placement of Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO).

Dr. Steven Chatfield appointed as Non-Executive Chairman of Bath based company Stablepharma Ltd, following an extensive career in vaccine R&D and Covid19 Pandemic.

PIR International recently partnered with Closed Loop Medicine in appointing Luba Greenwood as Non-Executive Chair

Cushman & Wakefield's Locating Science life sciences report wins top award from the Society of Property Researchers

Pension reform unlocks cash for UK life sciences, London Life Sciences Week and #bioProcessUK are here.

OMass Therapeutics, a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Professor Steven Charlton as Chief Scientific Officer (CSO).

Greywolf Therapeutics, a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system, has appointed Darlene Deptula-Hicks as Chief Financial Officer.